Compare AbCellera Biologics Inc (ABCL) vs Google Inc (GOOG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Google Inc — how do they compare? AbCellera Biologics Inc trades at $9.23 (market cap $2.99B), while Google Inc trades at $344.75 (market cap $4.20T). The key difference: Google Inc is far larger — about 1404.7× AbCellera Biologics Inc's market cap, and Google Inc pays a 0.26% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | GOOG | |
|---|---|---|
Market Cap | $2.99B | $4.20T |
Sector | Health | Technology |
52-Week High | $9.76 | $399.06 |
52-Week Low | $2.78 | $200.19 |
Enterprise Value | $2.58B | $4.09T |
Volume | — | 1,511,127 |
Dividend Yield | — | 0.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Google Inc
Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Read more on GOOG →
